Cushing's syndrome (veterinary)

Last updated
Cushing's syndrome disease
Other nameshyperadrenocorticism, spontaneous hypercortisolism
Cushings dachshund.jpg
Dachshund with Cushing's syndrome.
Specialty Endocrinology
Symptoms Enlarged stomach, lethargy, diabetes mellitus (cats)
TypesPituitary dependent, adrenal dependent, iatrogenic
Risk factors Certain breeds, bitches
Medication Lysodren, trilostane, L-Deprenyl
Frequency0.2% to 0.28% of dogs.
Named after Harvey Cushing

Cushing's syndrome disease, also known as hyperadrenocorticism and spontaneous hypercortisolism is a condition resulting from an endocrine disorder where too much adrenocorticotropic and cortisol hormones are produced causing toxicity in animals. [1] Cushing's is an umbrella term for conditions caused by elevated cortisol and adrenocorticotropic hormone levels.

Contents

Cushing's disease most commonly refers to pituitary-dependent hyperadrenocorticism, the most common condition of Cushing's syndrome, but 'Cushing's' is used to refer to all hyperadrenocorticism conditions. [2]

Cats are less likely to be diagnosed than dogs. [2] Cushing's occurs infrequently in hamsters. It may be more common but due to hamsters not being routinely treated it may go undiagnosed. [3]

Classification

Cutaneous atrophy in a dog with Cushing's Cutaneous atrophy dog.jpg
Cutaneous atrophy in a dog with Cushing's

Cushing's syndrome is classified as either pituitary-dependent, adrenal-dependent, or iatrogenic. [2] Pituitary-dependent Cushing's is caused by an adrenocorticotropic hormone producing pituitary tumour. Adrenal-dependent Cushing's is caused by an adrenal tumour. [4] Pituitary-dependent Cushing's accounts for 80-85% of cases. [5] Other forms have been described but they appear to be rare. [1] Ectopic adrenocorticotropic hormone secretion has been described in a German Shepherd dog, those reviewing the case noted it could be the result of an abdominal neuroendocrine tumour. [6] In one case a Vizsla was diagnosed with food-dependent hypercortisolemia. [7]

Description

Cortisol is a hormone produced in the adrenal glands. Cortisol is stored in these glands and released to help prepare the body for a fight-or-flight response. Cortisol makes the body mobilise fat and sugar stores and retain sodium and water by adjusting the metabolism. This allows the body to easily access stored resources. When the body is constantly exposed to this hormone the effects it results in Cushing's syndrome. [5] Blood levels of cortisol determine whether additional cortisol production is required via a negative feedback loop. An improper feedback loop due to a tumour or as a side effect of medication can result in an overproduction of adrenocorticotropic and cortisol hormones. Animals can only handle limited periods of elevated cortisol levels. [2]

Signs and symptoms

A horse with Cushing's Borse Cushing's.jpg
A horse with Cushing's

Cushing's has a wide variety of symptoms and most gradually appear with a slow onset. [8] The reason for the wide variety is due to how cortisol affects many different systems of the body. [2]

Symptoms in dogs include: [8]

Dermatological symptoms include: [2]

Rare clinical signs of Cushings include: [2]

A potbelly appearance is present in 90% of dogs with Cushing's, the cause is a hormonal redistribution of body fat and the breakdown of abdominal muscles. This breakdown of muscle protein leads to muscle weakness and lethargy. [8]

Other potential complications from Cushing's in dogs include proteinuria, glomerulosclerosis, pancreatitis, and gallbladder mucocele. [4] A study of 66 dogs with Cushing's found 91% of dogs to have either polyuria or polydipsia, 79% to have polyphagia, and 77% to have alopecia. [4]

Signs of ectopic adrenocorticotropic hormone secretion that accompany the rapidly progressing physical changes are high plasma levels of adrenocorticotropic hormones and cortisol alongside hypokalaemia. [6]

The symptoms of Cushing's in cats is similar to that of dogs. [8] For cats the most common reason for referral resulting in a diagnosis is diabetes mellitus. Abnormal dermatological findings were the most common reason for referral after physical examination in cats. [9] 80% of cats with Cushing's develop diabetes mellitus compared to 10% of dogs. [8] One study of cats found all 30 to have dermatological lesions, 87% to have polyuria or polydipsia, and 70% to have polyphagia. [9] Curling of the tips of the ears may occur. [2]

Signs in hamsters include nonpruritic alopecia which will slowly progress to complete hair loss except for vibrissae, hyperpigmentation, polyuria, polydipsia, and polyphagia. [3]

Co-morbidities

Animals with Cushing's syndrome often have a co-morbidity such as: diabetes mellitus, chronic urinary tract infections, systemic hypertension, and pulmonary thromboembolism. [2] The prevalence of systemic hypertension in dogs with Cushing's ranges between 31%-86%; however the reasons for this are unknown but hypotheses include: increased mineralocorticoid activity, decreased concentrations of nitric oxide, and increased renal vascular resistance. Studies have not found a difference in prevalence nor severity of systemic hypertension in dogs with pituitary-dependent versus adrenal-dependent Cushing's. No correlation has been identified with systolic blood pressure, age, sex, and neuter status. A relationship between systolic blood pressure and urinary protein to creatinine ratio or base coritsol levels has been inconsistently identified in studies. [4]

Causes

Abdominal distension and cutaneous atrophy in a dachshund with Cushing's syndrome Cushings dachshund 2.jpg
Abdominal distension and cutaneous atrophy in a dachshund with Cushing's syndrome

Pituitary-dependent Cushing's is caused by production of too much adrenocorticotropic hormone by a functioning pituitary tumour. The tumour may be benign or malignant. Adrendal-dependent Cushing's is caused by a primary adrenal disorder. [10]

Iatrogenic Cushing's is caused by long term use of corticosteroid-type medicine which can produce the same effects as cortisol produced by the body. [2]

Risk factors

Older dogs are more likely to present with Cushing's syndromes. Greater prevalence has been observed in some breeds such as the Yorkshire Terrier, Poodle (miniature), Miniature Dachshund, Boxer, [1] Irish Setter, and Basset Hound. [11] One study found bitches to be 1.4 times more likely to be diagnosed than dogs. [11]

Diagnosis

The presentation of clinical signs occurs with great variation due to the gradual onset of Cushing's. In cases where a tumour is the cause it may take months or years for a diagnosis to occur. [2] A study looking at 66 records of dogs with Cushing's found the duration of clinical signs before diagnosis to be between 1 and 36 months with a median of 8 months. [4]

Routine diagnostic testing for Cushing's includes: a complete blood count, urinalysis, and a serum biochemistry panel; however the abnormalities these tests detect are not specific to Cushing's. [2] Abnormalities that can be found in a complete blood count include: thrombocytosis, neutrophilia, lymphopenia, erythrocytosis, eosinopenia, and monocytosis. Abnormalities that can be found via serum biochemistry include: hyperglycaemia, hypercholesterolaemia, hypokalaemia, increased alkaline phosphatase concentration, alanine aminotransferase levels, creatinine concentration, lipase activity, and decreased urea concentration. [12]

Sonographic image of the left adrenal gland in a dog with adrenal hyperadrenocorticism NN links Hund Cushing adrenal.jpg
Sonographic image of the left adrenal gland in a dog with adrenal hyperadrenocorticism

Ultrasonography, CT scans, and MRI are used to identify any abnormality in the pituitary or adrenal gland. This helps diagnose if the patient has pituitary-dependent Cushing's or adrenal-dependent Cushing's. [2]

Cushing's may cause a breakdown of dermal proteins, causing shiny and thin skin, this can lead to secondary infection and is pathognomonic of Cushing's. [2]

Hamsters

Blood tests are not always practical for hamsters due to their small size; abdominal ultrasounds can be used to show adrenal gland enlargement. [3]

Prognosis

Prognosis varies based on the type of Cushing's, if the tumour is benign or malignant, and treatment method. [2] Median survival times for dogs of 662-900 days have been observed in pituitary-dependent cases treated with trilostane, and 353-475 days for adrenal-dependent cases treated with trilostane. [13] Survival rates of 72-79% have been observed in dogs with pituitary-dependent Cushing's four years after a hypophysectomy. Dogs affected by adrenal-dependent Cushing's that underwent an adrenalectomy had a median survival rate of 533-953 days. [13]

Treatment

X-Ray image of a calcinosis cutis in a dog with pituitary dependent hyperadrenocorticism Calcinosis cutis dog xray.jpg
X-Ray image of a calcinosis cutis in a dog with pituitary dependent hyperadrenocorticism

Treatment of Cushing's depends on the cause. It is possible to cure Cushing's if the tumour is small, benign, and located on the adrenal gland; however, this is not common. [2] [6] Hypophysectomy is an option for patients with good clinical signs and a high life expectancy. Inoperable pituitary tumours may be treated with radiation, this is therapeutic as can take up to 16 months for change to show. [6]

Mitotane

Mitotane, sold under the brand name lysodren, erodes the layers of the adrenal gland which produce corticosteroid hormones. Whilst the pituitary tumour will still excrete excessive stimulation, however the adrenal gland will no longer be capable of excess production of hormones. Mitotane was historically the only treatment used for pituitary dependent Cushing's in dogs and is relatively cheap. Disadvantages of mitotane as a treatment include the side effects and the requirement for blood test monitoring. Issues can arise when too much of the adrenal cortex becomes eroded. Approximately 30% of dogs will experience a reaction in response to treatment with mitotane, prednisone may be used as an antidote. In the event of a reaction mitotane treatment is discontinued until regrowth of the adrenal gland occurs. Occasionally the erosion is permanent and the dog will require treatment for cortisone deficiency. The risk of permanent or life-threatening reactions are between 2-5% based on two studies. Side effects of mitotane include diarrhoea, vomiting, anorexia, adipsia, and lethargy. [8]

Trilostane

Trilostane, sold under the brand name Vetoryl, inhibits the 3-beta-hydroxysteroid dehydrogenase enzyme. The enzyme is responsible for the production of cortisol and the inhibition of it will inhibit cortisol production. Trilostane has been identified by multiple studies as an effective treatment for Cushing's. Common side effects of trilostane include lethargy and anorexia. Addisonian reactions where the adrenal cortex dies have been reported, the reasons for this reaction are not known. Most reactions can be reversed with the ceasing of treatment; however permanent reactions are possible, unlike mitotane where permanent erosion is dose-dependent with trilostane permanent reactions are idiosyncratic, due to this blood testing monitoring is required. The risk of permanent or life-threatening reactions are between 2-3% based on two studies. [8]

L-Deprenyl

L-Deprenyl, sold under the brand name anipryl, does not target cortisol production, instead it directly addresses the tumour. Research on L-Deprenyl has shown that adrenocorticotropic hormone secretion in the intermediate area of the pituitary gland is controlled by the neurotransmitter dopamine. High levels of dopamine production will shutdown adrenocorticotropic hormone secretion. L-Deprenyl inhibits the enzymes responsible for the degradation of dopamine as well as stimulating the production of dopamine. Approximately 5% of dogs experience minor nausea, restlessness, and reduced hearing ability. The different mechanism of L-Deprenyl and that it breaks down into amphetamine and methamphetamine—which suppresses hunger— meaning the normal monitoring tests are not useful in dogs treated with L-Deprenyl. Independent studies showed roughly 20% of dogs to improve with L-Deprenyl compared to 80% with studies sponsored by the manufacturer. Advantages of L-Deprenyl include the lower risk of side effects and inability to cause hypoadrenocoritism. Disadvantages are the substantial cost and the comparatively longer time before improvements can be noticed compared to lysodren. Some veterinarians may use high doses of lysodren to induce hypoadrenocorticism (a deficiency of cortisone), as it is easier to treat. This is not a common method and is not used in some hospitals. [8]

Epidemiology

The prevalence of hyperadrenocorticism in dogs is between 0.2% and 0.28%. [14] [15]

An English study comparing dogs with hyperadrenocorticism to general hospital cases found smaller breeds, overweight dogs, dogs over the age of 9, and neutered dogs to be more likely to be diagnosed. [16]

See also

Related Research Articles

<span class="mw-page-title-main">Adrenal gland</span> Endocrine gland

The adrenal glands are endocrine glands that produce a variety of hormones including adrenaline and the steroids aldosterone and cortisol. They are found above the kidneys. Each gland has an outer cortex which produces steroid hormones and an inner medulla. The adrenal cortex itself is divided into three main zones: the zona glomerulosa, the zona fasciculata and the zona reticularis.

<span class="mw-page-title-main">Cushing's syndrome</span> Symptoms from excessive exposure to glucocorticoids such as cortisol

Cushing's syndrome is a collection of signs and symptoms due to prolonged exposure to glucocorticoids such as cortisol. Signs and symptoms may include high blood pressure, abdominal obesity but with thin arms and legs, reddish stretch marks, a round red face due to facial plethora, a fat lump between the shoulders, weak muscles, weak bones, acne, and fragile skin that heals poorly. Women may have more hair and irregular menstruation. Occasionally there may be changes in mood, headaches, and a chronic feeling of tiredness.

<span class="mw-page-title-main">Anterior pituitary</span> Anterior lobe of the pituitary gland

A major organ of the endocrine system, the anterior pituitary is the glandular, anterior lobe that together with the posterior lobe makes up the pituitary gland (hypophysis) which, in humans, is located at the base of the brain, protruding off the bottom of the hypothalamus.

<span class="mw-page-title-main">Addison's disease</span> Endocrine disorder

Addison's disease, also known as primary adrenal insufficiency, is a rare long-term endocrine disorder characterized by inadequate production of the steroid hormones cortisol and aldosterone by the two outer layers of the cells of the adrenal glands, causing adrenal insufficiency. Symptoms generally come on slowly and insidiously and may include abdominal pain and gastrointestinal abnormalities, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. Mood changes may also occur. Rapid onset of symptoms indicates acute adrenal failure, which is a clinical emergency. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.

Cushing's disease is one cause of Cushing's syndrome characterised by increased secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary. This is most often as a result of a pituitary adenoma or due to excess production of hypothalamus CRH that stimulates the synthesis of cortisol by the adrenal glands. Pituitary adenomas are responsible for 80% of endogenous Cushing's syndrome, when excluding Cushing's syndrome from exogenously administered corticosteroids. The equine version of this disease is Pituitary pars intermedia dysfunction.

<span class="mw-page-title-main">Adrenal insufficiency</span> Medical condition

Adrenal insufficiency is a condition in which the adrenal glands do not produce adequate amounts of steroid hormones. The adrenal glands—also referred to as the adrenal cortex—normally secrete glucocorticoids, mineralocorticoids, and androgens. These hormones are important in regulating blood pressure, electrolytes, and metabolism as a whole. Deficiency of these hormones leads to symptoms ranging from abdominal pain, vomiting, muscle weakness and fatigue, low blood pressure, depression, mood and personality changes to organ failure and shock. Adrenal crisis may occur if a person having adrenal insufficiency experiences stresses, such as an accident, injury, surgery, or severe infection; this is a life-threatening medical condition resulting from severe deficiency of cortisol in the body. Death may quickly follow.

<span class="mw-page-title-main">Metyrapone</span> Chemical compound

Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). It is part of the steroidogenesis inhibitor class of drugs.

<span class="mw-page-title-main">Pituitary adenoma</span> Human disease

Pituitary adenomas are tumors that occur in the pituitary gland. Most pituitary tumors are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.

<span class="mw-page-title-main">Endocrine gland</span> Glands of the endocrine system that secrete hormones to blood

Endocrine glands are ductless glands of the endocrine system that secrete their products, hormones, directly into the blood. The major glands of the endocrine system include the pineal gland, pituitary gland, pancreas, ovaries, testicles, thyroid gland, parathyroid gland, hypothalamus and adrenal glands. The hypothalamus and pituitary glands are neuroendocrine organs.

Nelson's syndrome is a disorder that occurs in about one in four patients who have had both adrenal glands removed to treat Cushing's disease. In patients with pre-existing adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas, loss of adrenal feedback following bilateral adrenalectomy can trigger the rapid growth of the tumor, leading to visual symptoms and hyperpigmentation. The severity of the disease is dependent upon the effect of ACTH release on the skin, pituitary hormone loss from mass compression, as well as invasion into surrounding structures around the pituitary gland.

<span class="mw-page-title-main">Mitotane</span> Chemical compound

Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing's syndrome. It is a derivative of the early insecticide DDT and an isomer of p,p'-DDDTooltip dichlorodiphenyldichloroethane (4,4'-dichlorodiphenyldichloroethane) and is also known as 2,4'-(dichlorodiphenyl)-2,2-dichloroethane (o,p'-DDD).

Sudden acquired retinal degeneration syndrome (SARDS) is a disease in dogs causing sudden blindness. It can occur in any breed, but female dogs may be predisposed. Approximately 4000 cases are seen in the United States annually.

<span class="mw-page-title-main">Dexamethasone suppression test</span> Medical test

The dexamethasone suppression test (DST) is used to assess adrenal gland function by measuring how cortisol levels change in response to oral doses or an injection of dexamethasone. It is typically used to diagnose Cushing's syndrome.

In humans and other animals, the adrenocortical hormones are hormones produced by the adrenal cortex, the outer region of the adrenal gland. These polycyclic steroid hormones have a variety of roles that are crucial for the body's response to stress, and they also regulate other functions in the body. Threats to homeostasis, such as injury, chemical imbalances, infection, or psychological stress, can initiate a stress response. Examples of adrenocortical hormones that are involved in the stress response are aldosterone and cortisol. These hormones also function in regulating the conservation of water by the kidneys and glucose metabolism, respectively.

<span class="mw-page-title-main">Trilostane</span> Chemical compound

Trilostane, sold under the brand name Vetoryl among others, is a medication which has been used in the treatment of Cushing's syndrome, Conn's syndrome, and postmenopausal breast cancer in humans. It was withdrawn for use in humans in the United States in the 1990s but was subsequently approved for use in veterinary medicine in the 2000s to treat Cushing's syndrome in dogs. It is taken by mouth.

Corticorelin is a diagnostic agent. It is a synthetic form of human corticotropin-releasing hormone (hCRH).

Hypoadrenocorticism in dogs, or, as it is known in people, Addison's disease, is an endocrine system disorder that occurs when the adrenal glands fail to produce enough hormones for normal function. The adrenal glands secrete glucocorticoids such as cortisol and mineralocorticoids such as aldosterone; when proper amounts of these are not produced, the metabolic and electrolyte balance is upset. Mineralocorticoids control the amount of potassium, sodium, and water in the body. Hypoadrenocorticism is fatal if left untreated.

<span class="mw-page-title-main">Adrenal gland disorder</span> Medical condition

Adrenal gland disorders are conditions that interfere with the normal functioning of the adrenal glands. Your body produces too much or too little of one or more hormones when you have an adrenal gland dysfunction. The type of issue you have and the degree to which it affects your body's hormone levels determine the symptoms.

<span class="mw-page-title-main">Amphenone B</span> Chemical compound

Amphenone B, or simply amphenone, also known as 3,3-bis(p-aminophenyl)butan-2-one, is an inhibitor of steroid hormone and thyroid hormone biosynthesis which was never marketed but has been used as a tool in scientific research to study corticosteroids and the adrenal glands. It acts as competitive inhibitor of 11β-hydroxylase, 17α-hydroxylase, 17,20-lyase, 21-hydroxylase, and 3β-hydroxysteroid dehydrogenase, as well as of cholesterol side-chain cleavage enzyme, thereby inhibiting the production of steroid hormones including glucocorticoids, mineralocorticoids, androgens, and estrogens. In addition, amphenone B inhibits the production of thyroxine by a thiouracil-like mechanism, specifically via inhibition of organic binding of iodine and uptake of iodide by the thyroid gland.

<span class="mw-page-title-main">Adrenalism</span>

Adrenalism describes the condition of an excessive or substandard secretion of hormones related to the adrenal glands, which are found directly superior to the kidneys. Adrenalism can be further distinguished as hyperadrenalism, referring to the excessive secretion of hormones, and hypoadrenalism, referring to the insufficient secretion of hormones.

References

  1. 1 2 3 Carotenuto, Gaia; Malerba, Eleonora; Dolfini, Costanza; Brugnoli, Francesca; Giannuzzi, Pasquale; Semprini, Giovanni; Tosolini, Paolo; Fracassi, Federico (2019-02-19). "Cushing's syndrome—an epidemiological study based on a canine population of 21,281 dogs". Open Veterinary Journal. 9 (1): 27–32. doi:10.4314/ovj.v9i1.5. ISSN   2218-6050. PMC   6500859 . PMID   31086762.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Ward, Charlotte (March 2024). "Cushing's Syndrome". The New Zealand Veterinary Nurse. 30 (109): 21–25.
  3. 1 2 3 Rhodes, Karen Helton; Werner, Alexander H. (2011-01-25). Blackwell's Five-Minute Veterinary Consult Clinical Companion. Ames, Iowa: Wiley-Blackwell. p. 551-552. ISBN   978-0-8138-1596-1.
  4. 1 2 3 4 5 García San José, Paula; Arenas Bermejo, Carolina; Clares Moral, Irene; Cuesta Alvaro, Pedro; Pérez Alenza, María Dolores (2020). "Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism". Journal of Veterinary Internal Medicine. 34 (5): 1768–1778. doi:10.1111/jvim.15841. ISSN   0891-6640. PMC   7517838 . PMID   32614466.
  5. 1 2 Brooks, Wendy (8 August 2017). "Cushing's Syndrome: Classifying the Type". Vin.com. Retrieved 15 March 2024.
  6. 1 2 3 4 Galac, S.; Kooistra, H.S.; Voorhout, G.; van den Ingh, T.S.G.A.M.; Mol, J.A.; van den Berg, G.; Meij, B.P. (2005). "Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone". Domestic Animal Endocrinology. 28 (3). Elsevier BV: 338–348. doi:10.1016/j.domaniend.2004.11.001. ISSN   0739-7240. PMID   15760674.
  7. ↑ Galac, S.; Kars, V.J.; Voorhout, G.; Mol, J.A.; Kooistra, H.S. (2008). "ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: A case report". The Veterinary Journal. 177 (1). Elsevier BV: 141–143. doi:10.1016/j.tvjl.2007.04.008. ISSN   1090-0233. PMID   17572120.
  8. 1 2 3 4 5 6 7 8 Rhodes, Karen Helton; Werner, Alexander H. (2011-01-25). Blackwell's Five-Minute Veterinary Consult Clinical Companion. Ames, Iowa: Wiley-Blackwell. p. 718-724. ISBN   978-0-8138-1596-1.
  9. 1 2 Valentin, S.Y.; Cortright, C.C.; Nelson, R.W.; Pressler, B.M.; Rosenberg, D.; Moore, G.E.; Scott-Moncrieff, J.C. (2014). "Clinical Findings, Diagnostic Test Results, and Treatment Outcome in Cats with Spontaneous Hyperadrenocorticism: 30 Cases". Journal of Veterinary Internal Medicine. 28 (2): 481–487. doi:10.1111/jvim.12298. ISSN   0891-6640. PMC   4858028 . PMID   24433386.
  10. ↑ Feldman, Edward C.; Nelson, Richard W.; Reusch, Claudia; Scott-Moncrieff, J. Catharine (2014-12-08). Canine and Feline Endocrinology. St. Louis, Missouri: Saunders. p. 377-451. ISBN   978-1-4557-4456-5.
  11. 1 2 Hoffman, J. M.; Lourenço, B. N.; Promislow, D. E. L.; Creevy, K. E. (2018). "Canine hyperadrenocorticism associations with signalment, selected comorbidities and mortality within North American veterinary teaching hospitals". Journal of Small Animal Practice. 59 (11): 681–690. doi:10.1111/jsap.12904. ISSN   0022-4510. PMC   6559942 . PMID   30039567.
  12. ↑ Bennaim, Michael; Shiel, Robert E.; Mooney, Carmel T. (2019). "Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 1: Pathophysiology, aetiology, clinical and clinicopathological features". The Veterinary Journal. 252: 105342. doi:10.1016/j.tvjl.2019.105342. PMID   31554593.
  13. 1 2 Schofield, Imogen; Brodbelt, David C.; Niessen, Stijn J. M.; Church, David B.; Geddes, Rebecca F.; Kennedy, Noel; O'Neill, Dan G. (2020). "Development and internal validation of a prediction tool to aid the diagnosis of Cushing's syndrome in dogs attending primary-care practice". Journal of Veterinary Internal Medicine. 34 (6): 2306–2318. doi:10.1111/jvim.15851. ISSN   0891-6640. PMC   7694798 . PMID   32935905.
  14. ↑ Carotenuto, Gaia; Malerba, Eleonora; Dolfini, Costanza; Brugnoli, Francesca; Giannuzzi, Pasquale; Semprini, Giovanni; Tosolini, Paolo; Fracassi, Federico (2019-02-19). "Cushing's syndrome—an epidemiological study based on a canine population of 21,281 dogs". Open Veterinary Journal. 9 (1). ScopeMed: 27–32. doi:10.4314/ovj.v9i1.5. ISSN   2218-6050. PMC   6500859 . PMID   31086762.
  15. ↑ O'Neill, D. G.; Scudder, C.; Faire, J. M.; Church, D. B.; McGreevy, P. D.; Thomson, P. C.; Brodbelt, D. C. (2016-06-09). "Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014" (PDF). Journal of Small Animal Practice. 57 (7). Wiley: 365–373. doi:10.1111/jsap.12523. ISSN   0022-4510. PMID   27279104.
  16. ↑ O'Neill, D. G.; Scudder, C.; Faire, J. M.; Church, D. B.; McGreevy, P. D.; Thomson, P. C.; Brodbelt, D. C. (2016-06-09). "Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014" (PDF). Journal of Small Animal Practice. 57 (7). Wiley: 365–373. doi:10.1111/jsap.12523. ISSN   0022-4510. PMID   27279104.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.